These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease]. Zhang Q Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823 [No Abstract] [Full Text] [Related]
14. Kawasaki disease or mucocutaneous lymph node syndrome. Has it a microbial aetiology? J Infect; 1984 Jul; 9(1):1-5. PubMed ID: 6501892 [No Abstract] [Full Text] [Related]
16. [Kawasaki's disease]. Rybojad M Ann Dermatol Venereol; 2001; 128(6-7):773-82. PubMed ID: 11460045 [No Abstract] [Full Text] [Related]
17. What Is the Role of Corticosteroids for the Treatment of Kawasaki Disease in Children? Gottlieb M; Rice M; Gore SR Ann Emerg Med; 2023 Feb; 81(2):140-142. PubMed ID: 36210244 [No Abstract] [Full Text] [Related]
18. Reassuring short-term effect of corticosteroids for Kawasaki disease. Williams K; Power B; Tiller G; Renton WD J Paediatr Child Health; 2023 Jan; 59(1):194-196. PubMed ID: 36495105 [No Abstract] [Full Text] [Related]
19. Revisiting steroids in the primary treatment of acute Kawasaki disease. Burns JC J Pediatr; 2006 Sep; 149(3):291-2. PubMed ID: 16939734 [No Abstract] [Full Text] [Related]
20. Treatment of Kawasaki disease. Taddio A; Rosé CD N Engl J Med; 2007 Jun; 356(26):2747; author reply 2748. PubMed ID: 17600908 [No Abstract] [Full Text] [Related] [Next] [New Search]